Literature DB >> 23060299

The influence of tissue ischemia on biomarker expression in colorectal cancer.

Birgitte M Havelund1, Dorte A Olsen, Rikke F Andersen, Karen-Lise G Spindler, Ivan Brandslund, Anders Jakobsen, Flemming B Soerensen.   

Abstract

The aim of the present study was to investigate the influence of fixation delay and the perioperative ischemia on hypoxia inducible factor (HIF)-1α gene expression, HIF-1α protein expression, and immunohistochemical (IHC) expression of HIF-1α, GLUT-1, Bcl-2, and Ki-67 in colorectal cancer. The study included 25 surgically removed colorectal tumors. Three sets of samples were collected readily after removal and exposed to 0, 30, and 60 minutes of delay of fixation or freezing. The perioperative ischemia time was registered. In each set of the samples, HIF-1α gene expression was analyzed by quantitative real time polymerase chain reaction, protein concentration of HIF-1α was assessed by enzyme-linked immunosorbent assay, and IHC staining of HIF-1α, GLUT-1, Bcl-2, and Ki-67 was performed. Preoperative formalin-fixed paraffin-embedded biopsies and whole sections of the entire tumor were analyzed by IHC. We found that the HIF-1α gene expression, HIF-1α protein concentration, and IHC expression of HIF-1α, GLUT-1, Ki-67, and Bcl-2 were not systematically affected by either the fixation or freezing delay of the tissue, the perioperative ischemia time, or the total ischemia time (perioperative ischemia+delay of fixation or freezing) in colorectal tumors. However, the intraindividual variation was quite large, which may question the use of individually, non-standardized-handled single biopsies or small tissue samples for analysis of often rather heterogenously expressed biomarkers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23060299     DOI: 10.1097/PAI.0b013e31826f4475

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  5 in total

1.  Impact of Preanalytical Factors on the Measurement of Tumor Tissue Biomarkers Using Immunohistochemistry.

Authors:  Aditi Bagchi; Zachary Madaj; Kelly B Engel; Ping Guan; Daniel C Rohrer; Dana R Valley; Emily Wolfrum; Kristin Feenstra; Nancy Roche; Galen Hostetter; Helen M Moore; Scott D Jewell
Journal:  J Histochem Cytochem       Date:  2021-03-01       Impact factor: 2.479

2.  Spatial normalization of reverse phase protein array data.

Authors:  Poorvi Kaushik; Evan J Molinelli; Martin L Miller; Weiqing Wang; Anil Korkut; Wenbin Liu; Zhenlin Ju; Yiling Lu; Gordon Mills; Chris Sander
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

3.  Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort.

Authors:  Elin Richardsen; Sigve Andersen; Samer Al-Saad; Mehrdad Rakaee; Yngve Nordby; Mona Irene Pedersen; Nora Ness; Thea Grindstad; Ingeborg Movik; Tom Dønnem; Roy Bremnes; Lill-Tove Busund
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

4.  Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort.

Authors:  G Fisher; Z H Yang; S Kudahetti; H Møller; P Scardino; J Cuzick; D M Berney
Journal:  Br J Cancer       Date:  2013-01-17       Impact factor: 7.640

5.  Biobanking of Fresh-Frozen Human Adenocarcinomatous and Normal Colon Tissues: Which Parameters Influence RNA Quality?

Authors:  Thibaut Galissier; Christophe Schneider; Saviz Nasri; Lukshe Kanagaratnam; Caroline Fichel; Christelle Coquelet; Marie-Danièle Diebold; Reza Kianmanesh; Georges Bellon; Stéphane Dedieu; Aude Marchal Bressenot; Camille Boulagnon-Rombi
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.